In the Phase 3 trial, the investigational 2 mg dose of Ozempic® (semaglutide) injection had a better blood glucose reduction compared to Ozempic® 1 mg in adults with type 2 diabetes – QNT Press Release5 years ago
The results of SURPASS-1 published by Eli Lilly in The Lancet show that in adult patients with type 2 diabetes, tirzepatide has superior A1C and weight loss compared with placebo – QNT Press Release5 years ago
A key study of Insulet’s Omnipod® 5 automatic insulin delivery system shows that results have improved throughout the life cycle from 2 to 70 years old – QNT Press Release5 years ago
Floyd Mayweather’s International Marketing Manager and ONE Entertainment CEO Brent Johnson outlines next steps – QNT Press Release5 years ago
PTON Final Deadline: Dear Investor Advisor ROSEN reminds Peloton Interactive, Inc. investors to pay attention to the important Monday deadline for securities class actions initiated by the company – PTON – QNT Press Release5 years ago
Kessler Topaz Meltzer & Check, LLP reminds investors of the securities fraud class action filed against Danimer Scientific, Inc. – QNT Press Release5 years ago
Final deadline for VWAGY: Leading law firm ROSEN encourages investors in Volkswagen to obtain legal advice before the important Tuesday deadline for securities class actions – VWAGY – QNT Press Release5 years ago
Italfarmaco announces top-line data from the Phase 2 trial of Givinostat in the treatment of patients with Baker’s muscular dystrophy – QNT Press Release5 years ago
Investor reminder: Kessler Topaz Meltzer & Check, LLP reminds shareholders to file a securities class action lawsuit against Skillz Inc. (SKLZ) – QNT Press Release5 years ago
Class action deadline: Kessler Topaz Meltzer & Check, LLP reminds investors of the securities fraud class action filed against Churchill Capital Corp IV – QNT Press Release5 years ago
Sana Biotechnology presented data at the ISSCR 2021 virtual annual meeting showing that the survival rate of transplanted low immune stem cells in non-human primates has no immunosuppression – QNT Press Release5 years ago
